Oral infection with high-risk "mucosal" human papillomaviruses (HPVs) within the genus *Alphapapillomavirus* has been identified as one of the important risk factors for a subset of head and neck squamous cell carcinomas \[[@CIT0001]\]. Over the last decade, oral HPV infection has become an important contributor to the global health burden \[[@CIT0001]\]. The proportion of HPV-associated oropharyngeal cancer has increased from 16.3% during the 1984--1989 period to 71.7% during the 2000--2004 period in the United States \[[@CIT0002], [@CIT0003]\]. A similar increasing trend has also been observed among young adults in Australia and many European countries \[[@CIT0002]\]. However, the reported prevalence of HPV-associated oropharyngeal squamous cell carcinoma in China is much lower (range 3.5%--17%), compared to that reported from the West \[[@CIT0005]\]. This may suggest an ethnic and/or geographic difference in the prevalence and disease attribution of oral HPV infection.

The majority of the characterized HPV types classified within the genera *Betapapillomavirus* and *Gammapapillomavirus* are referred to as "cutaneous" HPVs because of their well-recognized tropism for skin. However, recent studies have detected these "cutaneous HPVs" in mucosal sites, from cervical samples \[[@CIT0012], [@CIT0013]\], mouth wash samples \[[@CIT0014], [@CIT0015]\], and head and neck papilloma samples \[[@CIT0016], [@CIT0017]\]. At present, very little is known about the epidemiology and clinical course of beta- and gamma-HPV infections detected from mucosal sites.

The aim of this study was to elucidate the epidemiology of oral infection with mucosal and cutaneous HPVs in a large cohort of ethnic Chinese residing in an urban city, Hong Kong.

METHODS {#s5}
=======

Study Population and Sampling {#s6}
-----------------------------

The population of Hong Kong was estimated to be 7.23 million in mid-2014 \[[@CIT0018]\]. The proportion of males was 46.2%. The territory of Hong Kong is divided into 3 geographic clusters, namely the Hong Kong Island, Kowloon, and the New Territories, with Hong Kong Island being the most urban and the New Territories being the most rural \[[@CIT0019]\]. The number of domestic households was estimated to be 2.43 million, with an average domestic household size of 2.9 persons.

Cluster sampling is a commonly used sampling strategy \[[@CIT0020]\], where participants are invited to face-to-face interviews in community settings. The design of the present study was based on the proven concept of a previous study from our institution that adopted cluster randomization, which achieved a high response rate of 72.4% \[[@CIT0021]\]. We consecutively recruited participants for screening from a geographically representative sample of the general population of Hong Kong, which forms the sampling frame of this population-based survey. A proportional sampling methodology was adopted according to age groups (18--24, 25--34, 35--44, 45--54, 55--64 years), gender, and the geographic regions of residence (Hong Kong Island, Kowloon, or the New Territories), based on the population figures published in the latest version of the Hong Kong Census report. All permanent residents of Hong Kong aged 18--64 years, recruited by health talks and media announcements, were eligible for this study. Subjects who were unable to give consent, had symptoms suggestive of oropharyngeal cancer, or who had a medical condition rendering them unable to participate in the study were excluded.

Self-Administered Survey {#s7}
------------------------

On entering the study, all subjects completed a self-administered, anonymous survey that recorded their basic demographic profiles including age, gender, education level, household income, occupation, marital status, past medical history, and lifestyle habits including cigarette smoking, alcohol consumption, and sex history. A research assistant assisted those subjects who requested help in completing the survey, for reasons such as illiteracy, by reading the question items to them.

Oral Sample Processing and HPV Genotyping {#s8}
-----------------------------------------

Each participant provided an oral rinse sample collected in 0.9% normal saline after completing the survey. Approximately 1 mL of the oral rinse sample was centrifuged at 5000*g* for 5 minutes and DNA extracted from the pellet using the QIAamp DNA Mini Kit (Qiagen). Two recently developed novel PCR-based next-generation sequencing (NGS) assays targeting the consensus regions of HPV L1 open reading frame were used to detect and identify the full spectrum of human papillomaviruses including alpha-, beta-, and gamma-HPV types ([Supplementary Figure S1](#sup2){ref-type="supplementary-material"}) \[[@CIT0017], [@CIT0022]\]. For each assay, a pair of unique 12-bp barcodes was introduced to the PCR amplicon by forward and reverse primers. Successful amplicons with predicted fragment sizes were pooled at approximately equal molar DNA concentrations and sequenced on an Illumina MiSeq (Illumina) using 150-bp paired-end reads. The demultiplexed paired-end Illumina short reads passing the quality filter (≥Q20 and ≥50 bp) were merged into single reads using FLASh v1.2.11 \[[@CIT0023]\] and blasted against a genomes online database (gold) papilloma virus (PV) reference database using UPARSE software \[[@CIT0024]\]. Our PV reference database contains 387 fully characterized human (n = 225) and animal (n = 162) PV types, and 467 potential novel partial PV sequences. An operation taxonomic unit (OTU) count table giving the number of reads per sample per OTU was created using a 95% identity threshold with in-house developed scripts \[[@CIT0022]\]. The OTU taxonomy was classified at the type level based on sequence homology to the reference database: if OTUs hitting the reference database had ≥ 90% identities to a characterized PV type, they represented known viruses; those with 60%--89% identities were regarded as "uncharacterized" types and assigned with a unique identity. An HPV type was considered positive if the reads were ≥ 50. The processing from each NGS assay was separated while data was then combined to determine the presence of HPV DNA. HPV test results were not delinked to personal identifiers as clinical follow-up would be arranged for HPV-positive subjects for medicolegal reasons. We performed some measures to minimize the potential of contamination, where we processed the DNA extraction in a physically separated room from PCR amplification and introduced dual-index in the PCR primers. For each PCR amplification, multiple negative controls and random repeats were set.

HPV Classification and Phylogenetic Analysis {#s9}
--------------------------------------------

Tree topology of short OTU sequences was constructed using the pplacer v1.1.alpha17 \[[@CIT0025]\] by placing OTU reads on a PV reference tree to maximize phylogenetic likelihood according to a complete genome alignment. The reference tree was created using RAxML MPI v8.2.9 \[[@CIT0026]\] based on a complete genome alignment containing 387 PV types. A cutoff value of maximum likelihood ≥ 0.8 was set as confident assignment of PV type into each species. In a monograph from the International Agency for Research on Cancer (IARC) \[[@CIT0027]\], 12 alpha-HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59) were classified as "carcinogenic to humans" (Group 1) and were considered as high-risk HPV types in this study.

Statistical Analysis {#s10}
--------------------

The Statistical Package for Social Sciences 21.0 (Chicago, Illinois) software was used for all data entry and analysis. We examined associations of alpha-, beta-, and gamma-HPVs with participant demographic and lifestyle characteristics using conditional logistic regression models for matched risk sets to estimate ORs and 95% confidential intervals (CIs). Each epidemiological factor potentially associated with HPV infection was assessed by univariate analysis, and those with *P* \< .20 were selected for multivariate analysis using binary logistic regression models, where selection of the variable was backward and stepwise. A *P* value of ≤ 0.05 was regarded as statistically significant. The investigators performed the study with informed consent after approval by The Chinese University of Hong Kong -- New Territories East Cluster Clinical Research Ethics Committee (CREC 2014.708) and in accordance with the precepts of the Helsinki Declaration.

RESULTS {#s11}
=======

Participant Characteristics {#s12}
---------------------------

A total of 2410 subjects were invited to participate in the present study, and 1475 (61.2%) agreed to join ([Supplementary Figure S2](#sup2){ref-type="supplementary-material"}). Forty-nine subjects who were found to be ineligible, including those who were non-Chinese, were excluded. Characteristics of the 1426 subjects included for analysis are shown in [Table 1](#T1){ref-type="table"}. Briefly, the average age was 46.3 years (standard deviation \[SD\] 14.9), 47.7% were male, the majority were married or cohabited (63.6%), never smoked (79.2%), and were nondrinkers (77.7%). One-third (33.0%) reported having had oral sex, and 7.5% had had 2 or more sex partners in the past 2 years, while the majority (54.9%) reported having had only 1 sex partner during their lifetime. Furthermore, 72.4% reported teeth brushing before sleep for more than 90% of the time, 18.6% had dentures, and 30.9% suffered from gum disease in the past 3 months.

###### 

Characteristics of Study Participants (N = 1426)

                                                             N      \%
  ---------------------------------------------------------- ------ ------
  **Age (years**)                                                   
  ≤24^a^                                                     268    18.8
  25--34                                                     76     5.3
  35--44                                                     115    8.1
  45--54                                                     421    29.5
  55--64                                                     539    37.8
  ≥ 65                                                       7      0.5
  **Gender** ^**b**^                                                
  Male                                                       680    47.7
  Female                                                     745    52.2
  **Ethnicity**                                                     
  Chinese                                                    1426   100
  **Marital status**                                                
  Single                                                     426    29.9
  Married                                                    895    62.8
  Divorced/separated/widowed                                 93     6.5
  Cohabit                                                    12     0.8
  **Education level** ^**b**^                                       
  Middle school or below                                     312    21.9
  High school                                                423    29.7
  Matriculation/diploma/postsecondary/tertiary               690    48.4
  **Work status** ^**b**^                                           
  Student                                                    261    18.3
  Unemployed/part time                                       126    8.8
  Housewife                                                  181    12.7
  Retired                                                    173    12.1
  Full time                                                  682    47.8
  **Personal monthly income (HK\$**)^**b**^                         
  ≤ 3600                                                     452    31.7
  3601--20000                                                614    43.1
  ≥ 20001                                                    348    24.4
  Receive social allowance                                   7      0.5
  **Smoking** ^**b**^                                               
  Current                                                    120    8.4
  Never                                                      1130   79.2
  Exsmoker                                                   163    11.4
  **Drinking** ^**b**^                                              
  Drinker                                                    291    20.4
  Nondrinker                                                 1108   77.7
  Exdrinker                                                  24     1.7
  **HPV vaccination** ^**b**^                                       
  Yes                                                        106    7.4
  No                                                         1316   92.3
  **Teeth brushing before sleep** ^**b**^                           
  \>90%                                                      1032   72.4
  50--90                                                     164    11.5
  10--50                                                     112    7.9
  \<10 or never                                              110    7.7
  **Denture wearers** ^**b**^                                       
  Yes                                                        267    18.7
  No                                                         1112   78.0
  Not sure                                                   37     2.6
  **Gum disease in the past 3 months** ^**b**^                      
  Yes                                                        440    30.9
  No                                                         849    59.5
  Not sure                                                   124    8.7
  **Oral sex per month in the past 2 years** ^**b**^                
  Never                                                      937    65.7
  0--1 time                                                  266    18.7
  2--3 times                                                 127    8.9
  ≥ 4 times                                                  77     5.4
  **Number of sexual partner in the past 2 years** ^**b**^          
  0                                                          390    27.3
  1                                                          923    64.7
  2                                                          62     4.3
  ≥ 3                                                        45     3.2
  **Lifetime number of sexual partner** ^**b**^                     
  0                                                          280    19.6
  1                                                          783    54.9
  2                                                          130    9.1
  3                                                          75     5.3
  4                                                          24     1.7
  ≥ 5                                                        132    9.2

Study participants were asked to fill in a structured questionnaire to provide information on a voluntary basis, and were reassured that the information would not be linked to their personal identifiers. Questions left blank were regarded as missing for the purposes of analysis in this study.

^a^Includes 2 subjects of 16 years old, and 2 subjects of 17 years old.

^**b**^The numbers do not add up to 1426 due to missing data.

Prevalence of HPV Infection {#s13}
---------------------------

The prevalence of oral infection with all-type, alpha-, beta-, and gamma-HPV was 15.5% (95% CI, 13.7%--17.5%), 2.5% (95% CI, 1.8%--3.5%), 11.9% (95% CI, 10.3%--13.6%), and 2.9% (95% CI, 2.1%--3.9%), respectively ([Table 2](#T2){ref-type="table"}). Coinfection with more than 1 HPV type was detected in 47 (3.3%) subjects. Among the 47 coinfections, 38 (2.7%) were coinfected with multiple cutaneous (beta and/or gamma) types, 8 (0.6%) were coinfected with mucosal (alpha) and cutaneous (beta and/or gamma) types, and 1 (0.1%) was coinfected with multiple alpha-HPV types. Alpha-, beta-, and gamma-HPV infections showed a similar pattern of increase in prevalence with age, and the prevalence in men was higher than in women ([Figure 1](#F1){ref-type="fig"}).

###### 

Age- and Sex-Specific Prevalence of Oral Alpha-, Beta-, and Gamma-human Papillomavirus (HPV) Infections in 1426 Hong Kong Ethnic Chinese

                           N     \%
  ------------------------ ----- ------
  **Any HPV**              221   15.5
  **Alpha-HPV**            36    2.5
  Single infection         27    1.9
  Coinfection with other         
   Alpha-HPV               1     0.1
   Beta-HPV                5     0.4
   Gamma-HPV               1     0.1
   Beta- and Gamma-HPV     2     0.1
  **Beta-HPV**             169   11.9
  Single infection         124   8.7
  Coinfection with other         
   Alpha-HPV               5     0.4
   Beta-HPV                23    1.6
   Gamma-HPV               15    1.1
   Alpha- and Gamma-HPV    2     0.1
  **Gamma-HPV**            41    2.9
  Single infection         23    1.6
  Coinfection with other         
   Alpha-HPV               1     0.1
   Beta-HPV                15    1.1
   Gamma-HPV               0     0.0
   Alpha- and Beta-HPV     2     0.1

![Age- and sex-specific prevalence of oral alpha-, beta-, and gamma human papillomavirus infections.](jiy16001){#F1}

Distribution of HPV Types and Genera {#s14}
------------------------------------

The distribution of HPV types associated with their phylogenetic and oncogenic relationship is shown in [Figure 2](#F2){ref-type="fig"} and [Table 2](#T2){ref-type="table"}. Of the 36 subjects infected with mucosal (alpha-) HPVs, 11 (0.8%, 95% CI, 0.4%--1.4%) were infected with high-risk types, and 26 (1.8%, 95% CI, 1.3%--2.7%) were infected with low-risk types. HPV-16 was detected in 5 subjects (0.4%, 95% CI, 0.2%--0.8%), while no HPV-18 was found in this series. All subjects with high-risk HPV infection were examined by an otorhinolaryngologist and none were found to have suspicious oral or oropharyngeal mucosal lesions or oropharyngeal cancer.

![Distribution of human papillomavirus (HPV) types in oral rinse samples. The tree was inferred from the topology based on the complete genome alignment. The barplot on the right panel of the tree shows the number of samples positive for each type. Samples with coinfections were counted more than once. High-risk (HR) alpha-HPV, red; low-risk (LR) alpha-HPV, blue; any beta-HPV, orange; and any gamma-HPV, green.](jiy16002){#F2}

Beta-HPVs were the dominant cutaneous group in HPV-positive subjects, which was about 4 times more common than gamma-HPVs (prevalence of 11.9% vs 2.9%). The most common beta-HPV types were HPV-8 and HPV-98, each found in 21 subjects (1.5%, 95% CI, 1.0%--2.2%), followed by HPV-38, HPV-HIVGc36, HPV-21, HPV-22, and HPV-24 found in 16 (1.1%, 95% CI, 0.7%--1.8%), 14 (1.0%, 95% CI, 0.6%--1.6%), 13 (0.9%, 95% CI, 0.5%--1.6%), 13 (0.9%, 95% CI, 0.5%--1.6%), and 12 (0.8%, 95% CI, 0.5%--1.5%) subjects, respectively. The 2 most common gamma types were HPV-4 and HPV-SD2R, each found in 6 subjects (0.4%, 95% CI, 0.2%--0.9%). A total of 87 unique HPV types were detected in the surveyed subjects, including 22 (25.3%) alpha-HPV types, 40 (46.0%) beta-HPV types, and 25 (28.7%) gamma-HPV types ([Supplementary Table S1](#sup1){ref-type="supplementary-material"}). Among them, 3 and 6 potential novel beta-HPV (FA127, F031, SE48) and gamma-HPV types (SE80, SE54, F059, FA4, FA12, FA133) warrant further work to characterize their complete genomes.

Factors Associated With Oral HPV Infection {#s15}
------------------------------------------

Univariate analysis showed that oral alpha-, beta-, and gamma-HPV infections were associated with different epidemiological risk factor profiles ([Table 3](#T3){ref-type="table"}, [Figure 3](#F3){ref-type="fig"}). Smoking (crude odds ratio \[cOR\] 2.62, 95% CI, 1.32--5.19) and drinking (cOR 2.59, 95% CI, 1.32--5.08) were risk factors for alpha-HPV, but not for beta- or gamma-HPV infections. Furthermore, individuals reported to have had oral sex (cOR 2.56, 95% CI, 1.31--4.98) or 2 or more sexual partners (cOR 3.71, 95% CI, 1.65--8.35) in the past 2 years, or who had 4 or more sexual partners in their lifetime (cOR 3.77, 95% CI, 1.82--7.82) were associated with a higher prevalence of alpha-HPV, but not beta- or gamma-HPV infections.

###### 

Univariate Analysis of Epidemiologic Risk Factors of Oral Alpha-, Beta-, and Gamma-HPV Infections

                                                     Alpha-HPV                              Beta-HPV   Gamma-HPV                                                                                                                                                    
  -------------------------------------------------- -------------------------------------- ---------- ------------------- ------------------- ---------- ------------------- ------ ------------------- ------------ ------------------- ----- ------------------- ----------
  **Gender**                                         Female (N = 745)                       12         1.6                 Reference           **.021**   71                  9.5    Reference           **.004**     14                  1.9   Reference           **.018**
                                                     Male (N = 680)                         24         3.5                 2·24 (1·11--4·50)              98                  14.4   1·60 (1·16--2·21)                27                  4.0   2·16 (1·12--4·15)   
  **Age (years**)                                    18--54 (N = 876)                       19         2.2                 Reference           .253       81                  9.3    Reference           **\<.001**   22                  2.5   Reference           .473
                                                     55--64 (N = 539)                       17         3.2                 1·47 (0·76--2·85)              85                  15.8   1·84 (1·33--2·54)                17                  3.2   1·26 (0·67--2·40)   
  **Marital Status**                                 All other statuses (N = 531)           15         2.8                 Reference           .578       46                  8.7    Reference           **.004**     12                  2.3   Reference           .284
                                                     Married (N = 895)                      21         2.4                 0·83 (0·42--1·62)              123                 13.7   1·68 (1·18--2·40)                29                  3.2   1·45 (0·73--2·86)   
  **Education level**                                Middle school or below (N = 312)       8          2.6                 Reference           .649       46                  14.7   Reference           .186         10                  3.2   Reference           .066
                                                     High school (N = 423)                  13         3.1                 1·21 (0·49--2·94)              47                  11.1   0·72 (0·47--1·12)                18                  4.3   1·34 (0·61--2·95)   
                                                     Matriculation or above (N = 690)       15         2.2                 0·84 (0·35--2·01)              75                  10.9   0·71 (0·48--1·05)                13                  1.9   0·58 (0·25--1·34)   
  **Working status**                                 No full-time work (N = 741)            14         1.9                 Reference           .109       84                  11.3   Reference           .511         16                  2.2   Reference           .090
                                                     Full-time work (N = 682)               22         3.2                 1·73 (0·88--3·41)              85                  12.5   1·11 (0·81--1·54)                25                  3.7   1·72 (0·91--3·26)   
  **Personal monthly income (HK\$**)                 10000 below (N = 658)                  13         2.0                 Reference           .214       71                  10.8   Reference           .263         14                  2.1   Reference           .113
                                                     10001 above (N = 763)                  23         3.0                 1·54 (0·78--3·07)              97                  12.7   1·20 (0·87--1·67)                27                  3.5   1·69 (0·88--3·25)   
  **Smoking**                                        Never (N = 1130)                       22         2.0                 Reference           **.004**   127                 11.2   Reference           .235         29                  2.6   Reference           .231
                                                     Ex/current smokers (N = 283)           14         5.0                 2·62 (1·32--5·19)              39                  13.8   1·26 (0·86--1·86)                11                  3.9   1·54 (0·76--3·11)   
  **Drinking**                                       Nondrinker (N = 1108)                  21         1.9                 Reference           **.004**   131                 11.8   Reference           .970         28                  2.5   Reference           .134
                                                     Ex/current drinker (N = 315)           15         4.8                 2·59 (1·32--5·08)              37                  11.8   0·99 (0·67--1·46)                13                  4.1   1·66 (0·85--3·25)   
  **HPV vaccination**                                No (N = 1316)                          32         2.4                 Reference           .338       161                 12.2   Reference           .151         39                  3.0   Reference           .764
                                                     Yes (N = 106)                          4          3.8                 1·57 (0·55--4·54)              8                   7.6    0·59 (0·28--1·23)                2                   1.9   0·63 (0·15--2·64)   
  **Teeth brushing before sleep**                    Less than 90% of the time (N = 386)    12         3.1                 Reference           .404       60                  15.5   Reference           **.010**     17                  4.4   Reference           **.038**
                                                     More than 90% of the time (N = 1032)   24         2.3                 0·74 (0·37--1·50)              109                 10.6   0·64 (0·46--0·90)                24                  2.3   0·52 (0·28--0·97)   
  **Denture wearer**                                 No/not sure (N = 1149)                 30         2.6                 Reference           .734       125                 10.9   Reference           **.041**     29                  2.5   Reference           .156
                                                     Yes (N = 267)                          6          2.3                 0·86 (0·35--2·08)              41                  15.4   1·49 (1·02--2·18)                11                  4.1   1·66 (0·82--3·37)   
  **Gum disease in the past 3 months**               No/not sure (N = 973)                  25         2.6                 Reference           .939       118                 12.1   Reference           .773         32                  3.3   Reference           .197
                                                     Yes (N = 440)                          11         2.5                 0·97 (0·47--1·99)              51                  11.6   0·95 (0·67--1·35)                9                   2.1   0·61 (0·29--1·30)   
  **Oral sex in the past 2 years**                   Never (N = 937)                        16         1.7                 Reference           **.004**   111                 11.9   Reference           .753         24                  2.6   Reference           .497
                                                     Any number of times (N = 470)          20         4.3                 2·56 (1·31--4·98)              53                  11.3   0·95 (0·67--1·34)                15                  3.2   1·25 (0·65--2·41)   
  **Number of sexual partner in the past 2 years**   0--1 (N = 1313)                        28         2.1                 Reference           **.004**   153                 11.7   Reference           .892         39                  3.0   Reference           .764
                                                     ≥2 (N = 107)                           8          7.5                 3·71 (1·65--8·35)              12                  11.2   0·96 (0·51--1·79)                2                   1.9   0·62 (0·15--2·61)   
  **Lifetime number of sexual partner**              0--3 (N = 1268)                        25         2.0                 Reference           **.001**   145                 11.4   Reference           .150         36                  2.8   Reference           .798
  ≥4 (N = 156)                                       11                                     7.1        3·77 (1·82--7·82)   24                  15.4       1·41 (0·88--2·25)          5                   3.2          1·13 (0·44--2·93)                             

Study participants were asked to fill in a structured questionnaire to provide information on a voluntary basis, and were reassured that the information would not be linked to their personal identifiers. Questions left blank were regarded as missing for the purposes of analysis in this study.

Abbreviations: HPV, human papillomavirus; OR, odds ratio.

![Epidemiologic characteristics and risk of oral infection with alpha, beta, and gamma- human papillomavirus (HPV). The central symbols represent crude odds ratio and the lines indicate the 95% confidential interval from univariate analysis.](jiy16003){#F3}

A habit of teeth brushing before sleeping for more than 90% of the time was protective against beta-HPV (cOR 0.64, 95% CI, 0.46--0.90) and gamma-HPV (cOR 0.52, 95% CI, 0.28--0.97) infections. Subjects with dentures at the time of survey were associated with a marginal increase in the risk of beta-HPV (cOR 1.49, 95% CI, 1.02--2.18), but not alpha- or gamma-HPV infection.

Characteristics with a *P* value of ≤ 0·2 on univariate analysis were entered into a multivariate regression analysis to identify independent associations. Because cigarette smoking and alcohol drinking are highly correlated, they were entered independently into the multivariate regression analysis, and not simultaneously. Similarly, sexual behavior, including oral sex, number of sexual partners in the past 2 years, and lifetime partners, were entered separately into the multivariate regression analysis and not together. As a result, ex-/current smokers (adjusted odds ratio \[aOR\] 2.18, 95% CI, 1.08--4.41), ex-/current drinkers (aOR 2.33, 95% CI, 1.18--4.61), a positive history of oral sex in the past 2 years (aOR 2.24, 95% CI, 1.13--4.41), 2 or more sexual partners in the past 2 years (aOR 3.21, 95% CI, 1.41--7.31), and 4 or more lifetime sexual partners (aOR 2.91, 95% CI, 1.34--6.31) were found to be independently associated with an increased risk of oral alpha-HPV infection. Male gender (aOR 1.45, 95% CI, 1.04--2.03) and age ≥ 55 years (aOR 1.78, 95% CI, 1.28--2.47) were independent risk factors, whereas teeth brushing before sleep on \> 90% of evenings was an independent protective factor (aOR 0.68, 95% CI, 0.48--0.96) for oral beta-HPV infection. Male gender was the only independent risk factor observed for gamma-HPV infection (aOR 2.27, 95% CI, 1.18--4.38).

DISCUSSION {#s16}
==========

To the best of our knowledge, this is the first population-based study that investigated the epidemiology of oral infection with a full spectrum of HPV types in an urbanized ethnic Chinese population. While most of the published studies on oral HPV infection are limited to mucosal (alpha-) HPVs, we took advantage of the next-generation sequencing to interrogate both mucosal (alpha-) and cutaneous (beta- and gamma-) HPVs. Thus, we are able to compare the epidemiologic profile associated with oral infections of different genera of HPVs.

The prevalence rate of mucosal (alpha-) HPV infection observed in this study was lower than those reported from the Western countries. While we found the prevalence of 2.5% for alpha-HPV and 0.4% for HPV-16, the corresponding prevalence rates from a recent meta-analysis that pooled estimates from 29 studies, predominately from Western countries, 5.5% and 1.0% \[[@CIT0028], [@CIT0029]\]. Nevertheless, our prevalence rate for alpha-HPV was much higher than that reported from Anyang, a rural region of China (0.67%) \[[@CIT0030]\].

We observed a trend of increased prevalence of oral HPV infection with age, whereas others have reported a bimodal age-related peak with one at a younger age (30--34 years) and the other at an older age (60--64 years) \[[@CIT0028]\]. This could reflect age as a surrogate for different sets of risk factors among populations. Older subjects in our study could have lower immunity, more frequent denture use, periodontitis, gingivitis, or tooth loss. The higher prevalence of oral HPV among older people could also be due to a longer persistence of the virus, as reported in a prospective study \[[@CIT0032]\]. The age-specific prevalence of oral HPV infection needs further examination in large-scale surveys.

Tobacco smoking was found to be a risk factor for alpha-HPV infection. This finding is compatible with reports from other studies \[[@CIT0033]\]. It has been postulated that smoking can induce inflammation and suppress humoral immunity in the oral mucosa via its oxidative components such as nicotine, carbon monoxide, and other chemicals \[[@CIT0036]\]. Smoking might also promote mutagenesis that may favor the persistence of oral alpha-HPV infection \[[@CIT0029]\]. Furthermore, our results showed that men were more likely to be infected, which could be attributed to a higher probability of HPV transmission through oral sex on women compared to men \[[@CIT0037]\]. Another possible explanation is the hormonal differences between men and women, which may influence the persistence of oral alpha-HPV infection \[[@CIT0038]\] because women have higher seroconversion rates in response to genital infection and this may protect against oral infection \[[@CIT0039], [@CIT0040]\].

Our observation that oral sex was significantly associated with alpha-HPV infection is compatible with findings from previous studies \[[@CIT0030], [@CIT0034], [@CIT0035], [@CIT0040], [@CIT0041]\]. Nevertheless, there are studies that did not report any association between oral sex and HPV infection \[[@CIT0033], [@CIT0036], [@CIT0039]\], which could be due to the colinearity of sexual behaviors, including other sexually associated contacts such as deep kissing that precluded associating a particular sexual behavior with HPV infection \[[@CIT0029]\]. The present study did not distinguish whether subjects were oral sex providers or receivers. This could have different implications for male and female subjects, which could be examined in future studies.

Previous studies have shown that cutaneous (beta-/gamma-) HPVs are commonly found in anogenital areas and in the uterine cervix, but distinct associated risk factors were not identified \[[@CIT0013], [@CIT0040]\]. While we found that smoking, drinking, and sexual behavior were strongly associated with oral alpha-HPV, none of them was linked with beta-/gamma-HPVs suggesting that the route of transmission and factors favoring persistence were different between these 2 groups of viruses. The fact that oral cutaneous (beta-/gamma-) HPV infections were associated with a lack of teeth brushing before sleep might reflect the importance of oral hygiene in clearing these common infections, which probably do not have a strong intrinsic ability to persist. It would be worthwhile to carry out further studies to identify types and factors associated with HPV persistence and its clinical consequence.

Some limitations of this study are now addressed. Firstly, participants who joined the study might be more health conscious than the general population, and so the generalizability of these finding will need caution. On the contrary, some participants might have joined the study due to their particular risk factors for oral HPV infection, such as a history of oral sex that was reported by more than one-third of participants. In addition, lifestyle habits and sexual behaviors are difficult to accurately quantify, and underreporting due to social desirability biases might lead to residual confounding. Further, this is a cross-sectional study and one could not establish cause-and-effect relationship due to the possibility of reverse causality. Also, the "gold standard" collection and testing method for oral HPV is not yet widely recognized---some studies collected exfoliated cells from various sites of oral mucosa \[[@CIT0030]\], while others used oral rinses and gargles \[[@CIT0029]\]. Finally, the proportion of participants aged 25--34 years in the present study was relatively small, and this might reduce the reported estimate of alpha-HPV infection of the oral cavity because they are sexually more active. The lower proportion could, firstly, be explained by the fact that older participants usually report more favorable evaluation of health care than younger individuals \[[@CIT0042]\]. Second, younger subjects often have better perception of their own health and lower prevalence of self-reported health problems, and hence are less motivated to participate in clinical research \[[@CIT0043]\]. Third, the social exchange and benefit-cost theories stat that everyday commodities and shortage of time are among the main burdens for individuals' participation of nonincentive research \[[@CIT0044]\]. Our sample-collection sessions were only open during office hours. The time-effectiveness of joining our study was lower for people of working age than that for the older population.

The findings of our study have important public health and research implications. The factors found to be independently associated with oral HPV infection could form the target for future population-based disease prevention and education programs, for example daily teeth brushing. We recommend that future prospective longitudinal studies examine the rate of acquisition, persistence, and clearance of oral HPV infection. In addition, identifying cutaneous types, if any, that tend to persist and cause mucosal disease is worthy of study.
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